Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,090.50    -53.00 (-4.63%)
Bid:
1,089.50
Ask:
1,090.50
Spread: 1.00 (0.092%)
Market Cap: £9.22b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

13 Aug 2025 17:08

RNS Number : 2390V
Smith & Nephew Plc
13 August 2025
 

SMITH & NEPHEW PLC

 

13 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

 

On 13 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.

 

All figures in these columns are stated to 6 decimal places where applicable.

 

 

PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

 

The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting on 12 August 2025 of Conditional Share awards granted on 11 August 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability

Date of Transaction

2025 - 08 - 12

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Rohit Kashyap

(President, Advanced Wound Management and Global

PDMR

13.571365

23,201 (of which 5,670 were sold and 17,531 were retained.)

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIRTEIVLIE
Date   Source Headline
7th Jul 20219:00 amRNSNotice of Results
1st Jul 202111:13 amRNSTotal Voting Rights
1st Jun 202111:48 amRNSTotal Voting Rights
25th May 20216:15 pmRNSDirector/PDMR Shareholding
21st May 20214:30 pmRNSDirector/PDMR Shareholding
18th May 20215:15 pmRNSDirector/PDMR Shareholding
14th May 20214:00 pmRNSDirector/PDMR Shareholding
11th May 20212:32 pmRNSHolding(s) in Company
4th May 202112:38 pmRNSTotal Voting Rights
4th May 20219:45 amRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSTrading Statement
28th Apr 20217:00 amRNSDividend Declaration
14th Apr 20216:04 pmRNSResult of AGM
1st Apr 20211:15 pmRNSTotal Voting Rights
1st Apr 20219:00 amRNSDirector Declaration
31st Mar 202110:00 amRNSAdditional Annual General Meeting update
19th Mar 20211:00 pmRNSDirector/PDMR Shareholding
19th Mar 20219:00 amRNSNotice of Results
17th Mar 20213:30 pmRNSDirector/PDMR Shareholding
10th Mar 20215:45 pmRNSDirector/PDMR Shareholding
9th Mar 20215:48 pmRNSDirector/PDMR Shareholding
8th Mar 202111:30 amRNSDirector/PDMR Shareholding
1st Mar 20214:18 pmRNSAnnual Financial Report
1st Mar 20211:00 pmRNSTotal Voting Rights
18th Feb 20217:00 amRNSFourth Quarter and Full Year 2020 Results
11th Feb 20217:00 amRNSDirector Declaration
10th Feb 20217:00 amRNSJohn Ma joins Smith+Nephew's Board as NED
3rd Feb 20215:00 pmRNSDirector/PDMR Shareholding
1st Feb 20211:41 pmRNSBlock listing Interim Review
1st Feb 202112:30 pmRNSTotal Voting Rights
29th Jan 20217:00 amRNSNotice of Results
28th Jan 20219:15 amRNSDirector Declaration
14th Jan 202111:30 amRNSDirector/PDMR Shareholding
11th Jan 20217:00 amRNSTrading Statement
6th Jan 20211:00 pmRNSDirectorate Change
4th Jan 20215:46 pmRNSSmith+Nephew Completes Orthopaedics Acquisition
4th Jan 202111:00 amRNSTotal Voting Rights
22nd Dec 20209:00 amRNSDirector/PDMR Shareholding
1st Dec 202012:40 pmRNSTotal Voting Rights
24th Nov 20203:30 pmRNSDirector/PDMR Shareholding
16th Nov 20203:30 pmRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSDirector/PDMR Shareholding
10th Nov 20207:00 amRNSTotal Voting Rights
3rd Nov 202010:00 amRNSDirector/PDMR Shareholding
2nd Nov 20205:04 pmRNSDirector/PDMR Shareholding
2nd Nov 20202:45 pmRNSTotal Voting Rights
29th Oct 20203:05 pmRNSDirector/PDMR Shareholding
29th Oct 20207:00 amRNSTrading Statement
20th Oct 202010:00 amRNSKatarzyna Mazur-Hofsaess joins Smith+Nephew as NED
15th Oct 202011:52 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.